浙江富潤(600070.SH):富潤印染46%股權及富潤紡織51%股權流拍 三次掛牌底價2.01億元
格隆匯7月21日丨浙江富潤(600070.SH)公佈,公司以公開掛牌方式轉讓持有的浙江富潤印染有限公司(以下簡稱“富潤印染”)46%股權及浙江富潤紡織有限公司(以下簡稱“富潤紡織”)51%股權。截至2020年7月21日下午15時,無意向競買人蔘與本次報名。
現因前兩次公開掛牌轉讓均未能徵集到符合條件的意向受讓方,公司將於2020年7月23日起對富潤印染46%股權及富潤紡織51%股權進行第三次公開掛牌轉讓,第三次掛牌底價為2.01391億元,競買報名截止時間為2020年7月29日下午15時。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.